Fisher & Paykel Healthcare can’t predict the future

Fisher & Paykel Healthcare can’t predict the future
Chief executive Lewis Gradon told analysts there was a big opportunity ahead but couldn't say when the company would reach it. (Photo: Supplied)
Dan Brunskill
Medical device manufacturer Fisher & Paykel Healthcare is unquestionably in a better position than it was pre-covid, the question everyone is asking is: how much better? It was a question that not even chief executive Lewis Gradon was able to answer when asked by analysts after reporting earnings on Wednesday. The company declined to give earnings guidance for the third straight year, saying it was too hard to predict how much stock customers would want to hold and the possibility of future covid-19 surges.Unable to give guidance,...

More Markets

Me Today raises funds to be here tomorrow
Markets

Me Today raises funds to be here tomorrow

Shareholders have approved a capital raise of up to $2.59 million.

Foreign interest fuels M&A surge
Markets

Foreign interest fuels M&A surge

Private equity is quiet, but activity at highest level so far in 2025.